These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 30378106)

  • 1. Tumor microenvironment: Interactions and therapy.
    Najafi M; Goradel NH; Farhood B; Salehi E; Solhjoo S; Toolee H; Kharazinejad E; Mortezaee K
    J Cell Physiol; 2019 May; 234(5):5700-5721. PubMed ID: 30378106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts: Secretions, interactions, and therapy.
    Farhood B; Najafi M; Mortezaee K
    J Cell Biochem; 2019 Mar; 120(3):2791-2800. PubMed ID: 30260049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor microenvironment: promising therapeutic target].
    Kawasaki Y; Akiyama T
    Nihon Rinsho; 2015 Aug; 73(8):1283-7. PubMed ID: 26281679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy.
    de Looff M; de Jong S; Kruyt FAE
    Front Immunol; 2019; 10():1530. PubMed ID: 31333662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between tumors at anatomically distinct sites.
    Oliver AJ; Darcy PK; Trapani JA; Kershaw MH; Slaney CY
    FEBS J; 2021 Jan; 288(1):81-90. PubMed ID: 32248616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer.
    Anari F; Ramamurthy C; Zibelman M
    Future Oncol; 2018 Jun; 14(14):1409-1421. PubMed ID: 29848096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of miRNAs in cell signaling of cancer associated fibroblasts.
    Eichelmann AK; Matuszcak C; Hummel R; Haier J
    Int J Biochem Cell Biol; 2018 Aug; 101():94-102. PubMed ID: 29807095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Microenvironment of Lung Cancer and Therapeutic Implications.
    Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
    Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance.
    Maacha S; Bhat AA; Jimenez L; Raza A; Haris M; Uddin S; Grivel JC
    Mol Cancer; 2019 Mar; 18(1):55. PubMed ID: 30925923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment.
    Lv D; Fei Y; Chen H; Wang J; Han W; Cui B; Feng Y; Zhang P; Chen J
    Front Immunol; 2024; 15():1340702. PubMed ID: 38690275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular matrix (ECM) stiffness and degradation as cancer drivers.
    Najafi M; Farhood B; Mortezaee K
    J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
    Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
    Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mTOR Signaling in Tumor Microenvironment: An Overview.
    Conciatori F; Bazzichetto C; Falcone I; Pilotto S; Bria E; Cognetti F; Milella M; Ciuffreda L
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies.
    El-Tanani M; Rabbani SA; Babiker R; Rangraze I; Kapre S; Palakurthi SS; Alnuqaydan AM; Aljabali AA; Rizzo M; El-Tanani Y; Tambuwala MM
    Cancer Lett; 2024 Jun; 591():216894. PubMed ID: 38626856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. License for destruction: tumor-specific cytokine targeting.
    Johansson A; Hamzah J; Ganss R
    Trends Mol Med; 2014 Jan; 20(1):16-24. PubMed ID: 24169116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the microenvironment in solid tumors.
    Belli C; Trapani D; Viale G; D'Amico P; Duso BA; Della Vigna P; Orsi F; Curigliano G
    Cancer Treat Rev; 2018 Apr; 65():22-32. PubMed ID: 29502037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes: A Potential Therapeutic Tool Targeting Communications between Tumor Cells and Macrophages.
    Guo W; Li Y; Pang W; Shen H
    Mol Ther; 2020 Sep; 28(9):1953-1964. PubMed ID: 32563274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging microenvironmental synthetic lethalities to treat cancer.
    Metcalf KJ; Alazzeh A; Werb Z; Weaver VM
    J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy.
    Stakheyeva M; Riabov V; Mitrofanova I; Litviakov N; Choynzonov E; Cherdyntseva N; Kzhyshkowska J
    Curr Pharm Des; 2017; 23(32):4807-4826. PubMed ID: 28714406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.